BURLINGTON DRUG CO., INC. v. PFIZER INC.

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY RE LIPITOR ANTITRUST} MDL No. 2332 LITIGATION Master Docket No.: 3:12-cv-2389 This Document Relates To: (PGS/IBD) All End-Payer Class Actions MEMORANDUM This case is before the Court on End-Payor Plaintiffs’ Motion for Class Certification. (ECF No. 1251). In this motion, End-Payor Plaintiffs (hereinafter, “EPPs”) seek class certification on the basis that Defendant Ranbaxy Inc., Ranbaxy Laboratories Limited, and Ranbaxy Pharmaceuticals, Inc. (hereinafter, “Ranbaxy” or “Defendant”) engaged in an alleged “reverse payment settlement”…